Association of Bordetella pertussis with host immune cells in the mouse lung

Microbial Pathogenesis

Volumn 35, Issue 1, 2003, Pages 19-29

  Vandebriel, Rob J ^a   Hellwig, Sandra M M ^a   Vermeulen, Jolanda P ^a   Hoekman, Jan H G ^a   Dormans, Jan A M A ^a   Roholl, Paul J M ^a   Mooi, Frits R ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

FHA; Fimbriae; Macrophages; Mouse model; Pertussis; PMN

Indexed keywords

HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BORDETELLA PERTUSSIS; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL MODEL; FEMALE; FIMBRIA; HOST; IMMUNITY; IMMUNOFLUORESCENCE; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 0037675912     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(03)00087-1     Document Type: Article

References (43)

1. Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 28:1999;S112-S117.
2. Strebel P., Nordin J., Edwards K., et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis. 183:2001;1353-1359.
3. de Melker H.E., Conyn van Spaendonck M.A., Rumke H.C., van Wijngaarden J.K., Mooi F.R., Schellekens J.F. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerg Infect Dis. 3:1997;175-178.
4. Relman D., Tuomanen E., Falkow S., Golenbock D., Saukkonen K., Wright S. Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell. 61:1990;1375-1382.
5. Wardlaw C., Parton R. Pathogenesis and immunity in pertussis. 1988;Wiley, New York.
6. Hewlett E.L. Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J. 16:1997;S78-S84.
7. Saukkonen K., Burnette W.N., Mar V.L., Masure H.R., Tuomanen E.I. Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc Natl Acad Sci, USA. 89:1992;118-122.
8. Lobet Y., Feron C., Dequesne G., Simoen E., Hauser P., Locht C. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin. J Exp Med. 177:1993;79-87.
9. Goodwin M.S., Weiss A.A. Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect Immun. 58:1990;3445-3447.
10. Gross M.K., Au D.C., Smith A.L., Storm D.R. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc Natl Acad Sci USA. 89:1992;4898-4902.
11. Mouallem M., Farfel Z., Hanski E. Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion. Infect Immun. 58:1990;3759-3764.
12. Masure H.R. The adenylate cyclase toxin contributes to the survival of Bordetella pertussis within human macrophages. Microb Pathog. 14:1993;253-260.
13. Ewanowich C., Melton A., Weiss A., Sherburne R., Peppler M. Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect Immun. 57:1989;2698-2704.
14. Hazenbos W.L.W., Geuijen C.A.W., van den Berg B.M., Mooi F.R., van Furth R. Bordetella pertussis fimbriae bind to human monocytes via the minor fimbrial subunit FimD. J Infect Dis. 171:1995;924-929.
15. van 't Wout J., Burnette W., Mar V., Rozdzinski E., Wright S., Tuomanen E. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages. Infect Immun. 60:1992;3303-3308.
16. Hellwig S.M.M., van Oirschot H.F., Hazenbos W.L., van Spriel A.B., Mooi F.R., van de Winkel J.G. Targeting to Fc gamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J Infect Dis. 183:2001;871-879.
17. Friedman R.L., Nordensson K., Wilson L., Akporiaye E.T., Yocum D.E. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect Immun. 60:1992;4578-4585.
18. Mills K.H.G., Ryan M., Ryan E., Mahon B.P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun. 66:1998;594-602.
19. Cheers C., Gray D.F. Macrophage behaviour during the complaisant phase of murine pertussis. Immunology. 17:1969;875-887.
20. Khelef N., Bachelet C.M., Vargaftig B.B., Guiso N. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun. 62:1994;2893-2900.
21. Hellwig S.M.M., Hazenbos W.L., van de Winkel J.G., Mooi F.R. Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice. FEMS Immunol Med Microbiol. 26:1999;203-207.
22. Granstrom M., Granstrom G. Serological correlates in whooping cough. Vaccine. 11:1993;445-448.
23. Lenz D.H., Weingart C.L., Weiss A.A. Phagocytosed Bordetella pertussis fails to survive in human neutrophils. Infect Immun. 68:2000;956-959.
24. Mooi F.R., Jansen W.H., Brunings H., Gielen H., van der Heide H.G., Walvoort H.C., Guinee P.A. Construction and analysis of Bordetella pertussis mutants defective in the production of fimbriae. Microb Pathog. 12:1992;127-135.
25. Kimura A., Mountzouros K.T., Relman D.A., Falkow S., Cowell J.L. Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model. Infect Immun. 58:1990;7-16.
26. Hazenbos W.L.W., van den Berg B.M., van 't Wout J.W., Mooi F.R., van Furth R. Virulence factors determine attachment and ingestion of nonopsonized and opsonized Bordetella pertussis by human monocytes. Infect Immun. 62:1994;4818-4824.
27. Saukkonen K., Cabellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary localization. J Exp Med. 173:1991;1143-1149.
28. Rozdzinski E., Spellerberg B., Vanderflier M., et al. Peptide from a prokaryotic adhesin blocks leukocyte migration In vitro and in vivo. J Infect Dis. 172:1995;785-793.
29. Bassinet L., Gueirard P., Maitre B., Housset B., Gounon P., Guiso N. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun. 68:2000;1934-1941.
30. Tuomanen E., Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory epithelial cells. J Infect Dis. 152:1985;118-1125.
31. Weingart C.L., Weiss A.A. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun. 68:2000;1735-1739.
32. Geuijen C.A.W., Willems R.J.L., Bongaerts M., Top J., Gielen H., Mooi F.R. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect Immun. 65:1997;4222-4228.
33. Baorto D.M., Gao Z., Malaviya R., et al. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature. 389:1997;636-639.
34. Shin J.S., Gao Z., Abraham S.N. Involvement of cellular caveolae in bacterial entry into mast cells. Science. 289:2000;785-788.
35. Willems R.J., Geuijen C., van der Heide H.G., et al. Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of, FHA. Mol Microbiol. 11:1994;337-347.
36. Willems R.J.L., Kamerbeek J., Geuijen C.A.W., et al. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and bordetella parapertussis infections in a respiratory mouse model. Vaccine. 16:1998;410-416.
37. Verweij T.S.S. A simplified liquid culture medium for growth of Haemophilus pertussis. J Bacteriol. 58:1949;127-134.
38. Lewinsohn D.M., Bargatze R.F., Butcher E.C. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 138:1987;4313-4321.
39. Bilyk N., Holt P.G. The surface phenotypic characterization of lung macrophages in C3H/HeJ mice. Immunol. 74:1991;645-651.
40. Leenen P.J., de Bruijn M.F., Voerman J.S., Campbell P.A., van Ewijk W. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Meth. 174:1994;5-19.
41. Leenen P.J., Radosevic K., Voerman J.S., et al. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J Immunol. 160:1998;2166-2173.
42. Woodcock-Mitchell J., Eichner R., Nelson W.G., Sun T.T. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol. 95:1982;580-588.
43. Tseng S.C.G., Jarvinen M.J., Nelson W.G., Huang J.W., Woodcock-Mitchell J., Sun T.T. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell. 30:1982;361-372.